SavedAdd your journal

Journals / International Journal of Medical Biochemistry / 2019 / Cilt: 2 - Sayı: 1

A promising novel biomarker for embryogenesis and carcinogenesis: S100P protein

Uzay GÖRMÜŞ
Pages
30–34
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The S100P protein is discussed in this review in relation to its functions and possible usage in the clinical area, mainly focusing on potential use in cancer research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Over the past decade, many great improvements have been achieved in cancer detection.
📊
Key Findings & Data:In many aspects, S100 calcium-binding protein P (S100P), a protein that is encoded by the S100P gene, is an interesting and promising marker that can enable the detection of many aggressive cancers in the early stages.
💡
Conclusion & Impact:The S100P protein is discussed in this review in relation to its functions and possible usage in the clinical area, mainly focusing on potential use in cancer research.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Over the past decade, many great improvements have been achieved in cancer detection. Although there are many cancer biomarkers in use, unfortunately most of these biomarkers cannot yet be used efficiently for clinical purposes. Novel and reliable biomarkers are still required for the early detection and prognosis prediction of cancer. In many aspects, S100 calcium-binding protein P (S100P), a protein that is encoded by the S100P gene, is an interesting and promising marker that can enable the detection of many aggressive cancers in the early stages. S100P overexpression seems to be related to cancer aggression because of its capability to promote cell proliferation, invasion, and migration. Once we understand the molecular mechanisms better, S100P may be used as a specific biomarker and even a potential drug target for various cancers. The S100P protein is discussed in this review in relation to its functions and possible usage in the clinical area, mainly focusing on potential use in cancer research.

🔖

Cite This Article

GÖRMÜŞ, U. (2019). A promising novel biomarker for embryogenesis and carcinogenesis: S100P protein. International Journal of Medical Biochemistry, Cilt: 2 - Sayı: 1, 30–34. https://ajindex.com/articles/160902

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637–68
  2. Gribenko A, Lopez MM, Richardson JM 3rd, Makhatadze GI. Cloning, overexpression, purification, and spectroscopic characterization of human S100P. Protein Sci 1998;7:211–15
  3. Gilston BA, Skaar EP, Chazin WJ. Binding of transition metals to S100 proteins. Sci China Life Sci 2016;59:792–801
  4. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739–44
  5. Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer 2015;15:96–109
  6. Li F, Men X, Zhang W. S100 protein in breast tumor. Indian J Cancer 2014;51:67–71
  7. Boteanu RM, Suica VI, Uyy E, Ivan L, Dima SO, Popescu I, et al. Alarmins in chronic noncommunicable diseases: atherosclerosis, diabetes and cancer. J Proteomics 2016;153:21–9
  8. Dmytriyeva O, Pankratova O, Owczarek S, Sonn K, Soroka V, Ridley CM, et al. The metastasis-promoting S100A4 protein confers neuroprotection in brain injury. Nat Commun 2012;3:1197
  9. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med 2013;13:24–57
  10. Bertheloot D, Latz E. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol 2016;14:43–64
  11. Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acadof Sci 2008;1126:7–13
  12. Sorci G, Riuzzi F, Giambanco I, Donato R. RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta 2013;1833:101–9
  13. Hartman KG, McKnight LE, Liriano MA, Weber DJ. The evolution of S100B inhibitors for the treatment of malignant melanoma. Future Med Chem 2013;5:97–109
  14. Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, et al. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol 2011;35:590–8
  15. Winningham-Major F, Staecker JL, Barger SW, Coats S, Van Eldik LJ. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol 1989;109:3063–71
  16. Charmsaz S, Hughes É, Bane FT, Tibbitts P, McIlroy M,